ID 110783
著者
タカハシ, マサユキ Department of Urology, Institute of Health Biosciences, The University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
Teh, Bin T. Laboratory of Cancer Genetics, Van Andel Research Institute
カナヤマ, ヒロオミ Department of Urology, Institute of Health Biosciences, The University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
キーワード
gene expression profiling
renal cell carcinoma
prognosis
資料タイプ
学術雑誌論文
抄録
Renal cell carcinoma (RCC) is the 10th most common cancer in United States. It is a heterogeneous disease with various histologic types. Since high-throughput technologies such as microarrays have been introduced, molecular confirmation of previously known findings in RCC has been made and new molecular findings have emerged. We review the accumulating advances in this field and their clinical implications. The published data so far have proved to be significant and promising, and numerous microarray studies with larger number of cases are currently ongoing or being planned. Although various clinical parameters are being refined for diagnosis and prognosis, these data obtained by microarray studies will undoubtedly contribute to both and eventually impacts the treatment of RCC.
掲載誌名
The journal of medical investigation : JMI
ISSN
13431420
cat書誌ID
AA11166929
53
1-2
開始ページ
9
終了ページ
19
並び順
9
発行日
2006-02
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系